Zheng Quan Shi Bao Wang·2025-06-10 09:18Core Insights - The recombinant protein sector saw a rise of 1.42%, ranking 8th among concept sectors, with 26 stocks increasing in value, including Sai Sheng Pharmaceutical which hit a 20% limit up [1] - Major gainers in the sector included Jie Ya Co., Yi Pin Hong, and Zhong Yuan He He, with increases of 14.83%, 9.40%, and 6.85% respectively [1] - The sector experienced a net outflow of 223 million yuan in capital, with 13 stocks receiving net inflows, and 10 stocks exceeding 10 million yuan in net inflows [2] Stock Performance - Sai Sheng Pharmaceutical led the net inflow with 165 million yuan, followed by Zhong Yuan He He, Ke Xing Pharmaceutical, and Yi Pin Hong with net inflows of 62.43 million yuan, 36.45 million yuan, and 28.04 million yuan respectively [2][3] - The top stocks by net inflow ratio included Sai Sheng Pharmaceutical at 23.69%, *ST Su Wu at 11.75%, and Ke Xing Pharmaceutical at 9.86% [3] Market Trends - The recombinant protein sector's performance was contrasted by other sectors, with the transgenic sector leading with a 3.15% increase, while EDR concept saw a decline of 2.63% [2] - The overall market sentiment reflected a mixed performance across various sectors, indicating selective investor interest [2]